Recent robust evidence suggests that both NKs and CD8+ T cells (tumor-infiltrating lymphocytes (TILs)) are associated with better prognosis and are able to “sculpture” the neoplastic population by eliminating some neoplastic clones, including those carrying KRAS mutations (8–11). This evidence concerns the gene KRAS and neoplasm.